Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease. Circumvent is funded by NIH/NINDS, YC Bio, Heritage Provider Network, and the Longevity Fund
Company Details
- Employees
- 9
- Founded
- -
- Address
- Portland, Oregon, Us
- in****@****als.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- circumventpharmaceuticals.com
- HQ
- Portland, Oregon
Circumvent Questions
Circumvent's website is circumventpharmaceuticals.com
Circumvent's LinkedIn profile is https://www.linkedin.com/company/circumvent-pharmaceuticals
Circumvent has
9 employees.
View email and phone details for 9
employees at Circumvent.
Circumvent's industry is
Biotechnology Research
Circumvent's top competitors are
Sedia Biosciences Corp.,
Cardax, Inc.,
Neurano Bioscience,
Bridge Therapeutics Inc.,
Sparrow Pharmaceuticals, Inc.,
Probioferm,
Twist Bioscience,
Spectragen Informatics, Llc,
Pdx Pharmaceuticals,
Veana Therapeutics, Llc..
Circumvent's support email address is info@circumventpharmaceuticals.com
Circumvent's categories are Biotechnology Research
Circumvent's founding year is 2017
